Simor AE - Search Results

1

Symptom reporting compared with audiometry for the detection of cochleotoxicity in patients on long-term aminoglycoside therapy.

Palmay L, Walker SA, Walker SE, Simor AE. Palmay L, et al. Among authors: simor ae. Ann Pharmacother. 2011 May;45(5):590-5. doi: 10.1345/aph.1P729. Epub 2011 Apr 26. Ann Pharmacother. 2011. PMID: 21521861

2

Impact of antimicrobial stewardship in critical care: a systematic review.

Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Kaki R, et al. J Antimicrob Chemother. 2011 Jun;66(6):1223-30. doi: 10.1093/jac/dkr137. Epub 2011 Apr 2. J Antimicrob Chemother. 2011. PMID: 21460369 Review.

3

Identification of predictors of early infection in acute burn patients.

Schultz L, Walker SA, Elligsen M, Walker SE, Simor A, Mubareka S, Daneman N. Schultz L, et al. Burns. 2013 Nov;39(7):1355-66. doi: 10.1016/j.burns.2013.04.009. Epub 2013 May 8. Burns. 2013. PMID: 23664774

4

Determination of tobramycin pharmacokinetics in burn patients to evaluate the potential utility of once-daily dosing in this population.

Vella D, Walker SA, Walker SE, Daneman N, Simor A. Vella D, et al. J Burn Care Res. 2014 Jul-Aug;35(4):e240-9. doi: 10.1097/BCR.0b013e3182a226fb. J Burn Care Res. 2014. PMID: 24043237

5

Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.

Kim J, Walker SA, Iaboni DC, Walker SE, Elligsen M, Dunn MS, Allen VG, Simor A. Kim J, et al. Antimicrob Agents Chemother. 2014 May;58(5):2830-40. doi: 10.1128/AAC.01718-13. Epub 2014 Mar 10. Antimicrob Agents Chemother. 2014. PMID: 24614381 Free PMC article.

6

Point prevalence survey of antimicrobial utilization in a Canadian tertiary-care teaching hospital.

Lee C, Walker SA, Daneman N, Elligsen M, Palmay L, Coburn B, Simor A. Lee C, et al. J Epidemiol Glob Health. 2015 Jun;5(2):143-50. doi: 10.1016/j.jegh.2014.06.003. Epub 2014 Aug 8. J Epidemiol Glob Health. 2015. PMID: 25922323 Free PMC article.

7

Impact of hospital length of stay on the distribution of Gram negative bacteria and likelihood of isolating a resistant organism in a Canadian burn center.

Wanis M, Walker SAN, Daneman N, Elligsen M, Palmay L, Simor A, Cartotto R. Wanis M, et al. Burns. 2016 Feb;42(1):104-111. doi: 10.1016/j.burns.2015.07.010. Epub 2015 Nov 5. Burns. 2016. PMID: 26547832

8

Antibiotic Use and Need for Antimicrobial Stewardship in Long-Term Care.

Wu LD, Walker SA, Elligsen M, Palmay L, Simor A, Daneman N. Wu LD, et al. Can J Hosp Pharm. 2015 Nov-Dec;68(6):445-9. doi: 10.4212/cjhp.v68i6.1500. Can J Hosp Pharm. 2015. PMID: 26715780 Free PMC article.

9

A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.

Lee C, Walker SAN, Walker SE, Seto W, Simor A, Jeschke M. Lee C, et al. Burns. 2017 Dec;43(8):1766-1774. doi: 10.1016/j.burns.2017.05.009. Epub 2017 Jun 21. Burns. 2017. PMID: 28647460 Clinical Trial.

10

Steady-State Pharmacokinetics of Oral Ciprofloxacin in Continuous Cycling Peritoneal Dialysis Patients: Brief Report.

Lee C, Walker SAN, Palmay L, Walker SE, Tobe S, Simor A. Lee C, et al. Perit Dial Int. 2018 Jan-Feb;38(1):73-76. doi: 10.3747/pdi.2017.00052. Perit Dial Int. 2018. PMID: 29311199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters